NEW YORK (PRWEB)
October 19, 2022
The Healthcare Technology Report is pleased to announce The Top 25 Healthcare Technology COOs of 2022. The companies represented on this year’s list are some of the most successful and innovative in the healthcare technology industry, and that is due in no small part to the efforts of their chief operating officers. These awardees have not only expertly overseen the day-to-day operations of their companies, but they have also crafted business strategies that have helped their organizations rise to the top amidst an industry inundated with competition.
Some of the distinguished COOs on this year’s list include Thomas Denny of the Duke Human Vaccine Institute, which together with the Center for HIV/AIDS Vaccine Immunology is working to develop vaccines and therapeutics for HIV and other emerging infections. Meanwhile, Chris Chi’s Monogram Health is providing an innovative renal care model and a data-driven array of clinical managed services, including complex case and disease management, utilization management, and medication therapy management. And Cue Health’s David Arida has helped the San Diego biotech research company launch major new testing offerings, with a novel molecular test for the flu and COVID-19 viruses currently awaiting FDA approval.
The awardees on this year’s list are responsible for running companies across healthcare technology. From vaccines to renal care, virus testing, cancer treatment, and pharmaceuticals, among many other specialties, these companies are addressing every aspect of patient health and well-being. Through their vital work, these COOs are helping to improve patient outcomes while at the same time operating massively successful companies. Please join us in celebrating The Top 25 Healthcare Technology COOs of 2022.
Ryan Fukushima (Tempus Labs, Inc.), Brady Shirley (Enovis), Michael Dingle (TELUS Health), Thomas Denny (Duke Human Vaccine Institute), Chris Chi (Monogram Health), David Arida (Cue Health), Chris Tovey (Jazz Pharmaceuticals), Matt Miller (The Oncology Institute), Jennifer Jarrett (Arcus Biosciences), Eric Venker (Roivant Sciences), Stephen Gillett (Verily), Will Abbott (Carbon Health), Jared Fix (Alto Pharmacy), Patrick Bilbo (Organogenesis), Melissa Baird (Hims & Hers Health), DB Kartik (CorEvitas, LLC), Dan Raffi (Sim&Cure), Blake Watterson (iFIT), Neil Owens (Medicure), Joseph Cucolo (Canary Medical), Erwin Estigarribia (InterVenn Biosciences), Melissa Teran (Alife Health), Mark Gilmartin (T-Pro), Nicolas Fauchoux (Biotrial), Mukul Jain (Senseonics).
The full article can be read at https://thehealthcaretechnologyreport.com/
About The Healthcare Technology Report
The Healthcare Technology Report provides market research and insights, business news, investment activity updates, and important corporate developments related to the healthcare technology sector. Based in New York City, the firm is run by a seasoned team of editors, writers, and media professionals highly knowledgeable on healthcare technology and the various companies, executives, and investors that make up the sector.
Share article on social media or email: